Day: September 25, 2020
2020年9月24日星期四2020年上半年净利润达2020万欧元
Bombardier establishes new Bulgarian legal entity and opens project management office in Sofia
Written by Customer Service on . Posted in Public Companies.
Bombardier Transportation Bulgaria LLC to support the country’s ongoing rail modernizationAnnouncement shows Bombardier’s commitment to deepening its strategic partnership with the Bulgarian rail industryBERLIN, Sept. 25, 2020 (GLOBE NEWSWIRE) — Note to editors: To view the photo associated with this press release, please visit the following link: https://www.globenewswire.com/NewsRoom/AttachmentNg/ec0819bf-656a-48d3-90dc-3f12dd8bacc9Global mobility technology leader Bombardier Transportation has established a new legal entity in Bulgaria as well as a project management office in the capital city of Sofia. Bombardier Transportation Bulgaria LLC will enable Bombardier to strengthen its support for existing and future rail projects in the country and continue to work closely with the Bulgarian Railways as well as local partners and...
Q-Gold Announces Exploration Program at Past-Producing High-Grade Foley Gold Mine Complex, Ontario
Written by Customer Service on . Posted in Public Companies.
TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce its 2020-2021 exploration program at its wholly-owned Foley Gold Mine complex, near the town of Mine Centre, Ontario. Q-Gold will drill targets at the past-producing Foley Gold Mine; a high-grade gold-vein system with over 5,900 m of NI 43-101 compliant drilling with results of up to 53.47 g/t Au over 1.5 m and 106.7 g/t Au over 0.23 m. Previous records indicate that 10,500 tons of ore at 14 g/t was mined from stopes at the 100’ level with 5,267 oz of gold recovered between 1898 – 1900.Q-Gold will conduct an estimated 3,000 m diamond drill program to test the high-grade discovery potential at the Foley Gold Mine, including both shallow and deeper holes. Q-Gold’s objective at Mine Centre is to complete an...
Lexibook® lance une nouvelle gamme d’ordinateurs éducatifs et bilingues pour la rentrée !
Written by Customer Service on . Posted in Public Companies.
Les Ulis, le 25 Septembre 2020Lexibook® lance une nouvelle gamme d’ordinateurs éducatifs et bilingues pour la rentrée !Lexibook continue d’accompagner les enfants dans l’apprentissage en élargissant sa gamme de jouets électroniques éducatifs avec un nouvel ordinateur bilingue !Référence: JC598i1 / PVPC: 29,99€Disponible à partir d’octobre 2020Cette gamme complète d’ordinateurs éducatifs permet d’apprendre en s’amusant et d’accompagner l’enfant dans la découverte des apprentissages scolaires : lettres, orthographe, vocabulaire, chiffre, calcul, musique, logique et même l’Anglais !Cette année le contenu est enrichi avec plus d’activités, un écran plus grand et une multitude d’animations ! Sa forme compacte avec une souris, un clavier complet et un écran confère un design réaliste à cet ordinateur !Un ordinateur éducatif bilingue avec 124...
LAURENT-PERRIER: Communiqué de nomination
Written by Customer Service on . Posted in Public Companies.
Groupe Laurent-Perrier Tours-sur-Marne, le 24 septembre 2020
Laurent-Perrier: Release
Written by Customer Service on . Posted in Public Companies.
Groupe Laurent-Perrier Tours-sur-Marne, 24st September 2020Release
Uniserve reports results for fiscal year ended May 31, 2020
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) — Uniserve Communications Corporation (“Uniserve”) a provider of IT solutions and services to business and residential customers in Canada wishes to announce its annual fiscal 2020 financial results. Revenues for fiscal 2020 were $12,359K as compared to $12,251K for the prior fiscal year, an increase of 1%. The annual fiscal 2020 Operating loss was $1,632K compared to an operating loss of $2,507K for the prior fiscal year. Net loss for fiscal 2020 was $3,496K as compared to $3,009K for the prior fiscal year. Included in the current year Net Loss were impairment charges totaling $1,772K. During the year Uniserve focused on reducing operational costs and improving processes across the organization.About UniserveUniserve Communications Corporation is a 2018 TSX Venture...
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
ATLANTA, GA, Sept. 24, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the pricing of its underwritten public offering of 2,560,000 units at a price to the public of $5.00 per unit. Each unit issued in the offering consists of one share of common stock (or pre-funded warrant to purchase common stock in lieu thereof) and one warrant to purchase one share of common stock at an exercise price of $5.00. The common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants are immediately separable and will be issued separately. The common stock and warrants are expected to begin trading on the Nasdaq Capital Market,...
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial
Written by Customer Service on . Posted in Public Companies.
SUWON, Republic of Korea, Sept. 24, 2020 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to evaluate the efficacy of OLX10010 as an adjunct therapy to reduce the recurrence of hypertrophic scars after scar revision surgery.Hypertrophic scars are the result of an overgrowth of collagen in the dermis (the skin’s next layer) that may cause functional impairment and cosmetic disfigurement. Hypertrophic scarring occurs in 40% to 70% of patients following surgery. Currently, there is no FDA-approved drugs and few treatments supported by well-designed prospective studies.The purpose of this prospective, randomized, double-blind, intra-subject, placebo-controlled...
Prelude Therapeutics Announces Pricing of Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
WILMINGTON, Del., Sept. 24, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Prelude, before deducting underwriting commissions and offering expenses, are expected to be approximately $158.2 million. All of the shares of common stock are being offered by Prelude Therapeutics. In addition, Prelude Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,248,750 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.The shares are expected to begin trading on the Nasdaq Global Select Market on September 25, 2020...